Topic

Articles

Exploring the importance of analytics as a means of staying competitive in the commercial pharmaceutical market.

Competing in Commercial Pharmaceuticals: Get Formal and Familiar with Analytics

Julian Upton is Pharmaceutical Executive’s European and Online Editor. He can be reached at 

Sameer Lal and Sandeep Gantotti discuss the building of a next-gen medical information practice to modernize its operations and unlock its value to the wider organization and to HCPs.  

Moving MI Forward

Industry’s tardy shift to cloud-based solutions looks set to gather pace in 2021.

More Cloud on the Horizon for Pharma

Going beyond traditional market segmentation to understand the technological and data analytics capacity of target customers.

Bringing Data to Life: How Tech-Savvy Life Sciences Companies Can Better Serve the Healthcare Sector

The pandemic has raised the stakes for companies pursuing new data-harnessing capabilities in contract management and KPI benchmarking and tracking.

A ‘Sign’ of the Times: Digital Contract Transformation

To realize the promise of genomics, pharma must be prepared to mine the data more effectively.

The Emergence of Genomics 2.0: Advancing with Data

Janardan Prasad is CBO and Head of Life Sciences at Lore IO, providers of a pre-built, AI-powered common data model that enables unified data views and faster vendor onboarding. To learn more, visit the company at 

Owning a self-service data platform allows emerging pharma and biotech companies to accelerate past data engineering intricacies and focus on ad-hoc analytics to discern how their data can help them meet objectives for clinical operations, medical affairs, and commercial teams.

How A Self-Service Data Platform for Life Sciences Analytics Can Fast-Track Drug Readiness

Utilizing natural language processing technologies to improve search capabilities and advance the development of therapies.

Accelerating Rare Disease Drug Development with NLP: Three Use Cases

. He has more than 20 years of experience in management consulting and helps biopharmaceutical companies improve their data and analytical capabilities, as well as their brand commercialization and portfolio optimization strategies. Contact him at 

While patient support providers play an important role in keeping patients on therapy, biopharma companies have a great opportunity to push analytical sophistication beyond what many of these providers currently offer.

How Biopharma Can Rev Up the Analytics Engine to Boost Patient Compliance

With nearly 25 years of experience in driving strategy & commercialization efforts in Biotech & Pharma, with an exclusive focus in Life Sciences (LS) strategic planning and industry marketing efforts for enterprise software solutions, Ferdi Steinmann is responsible for the LS global industry strategy development at 

Ferdi Steinmann looks at pharma's current relationship with AI and how it is set to evolve.

Pharma and AI: 2021 and Beyond

How technology can maximize use of manufacturer copay and patient assistance programs.

Making Medication Assistance Program Solutions Work for You

Todd Nichols, chief commercial officer of Alkermes, gives his top three recommendations for going all-in to digitally transform the frontline sales team.

Are C-Suites Ready to Go All-In with A Digital Engagement Model for Their Frontlines?

The COVID-19 pandemic has shifted the adoption of digital platforms in pharma and has made the industry reconsider which technologies can improve global health moving forward.

Beyond the Data: Is Blockchain the Answer to Improving Global Health?

are the Vice President of Compliance Technology and Director of Compliance Technology, respectively, for Porzio Life Sciences.

Whether your company already has a data-driven compliance program in place or is contemplating building one, Michael O'Connor and Isha Arora outline four things the DOJ is now focused on that your compliance team needs to know.

The Department of Justice is Watching: Building a Data-Driven Compliance Program

Following her own experience, a health tech entrepreneur turned to AI to better guide other patients through their treatment journeys.

Expediting the Cancer Treatment Path

Implementing an efficient means of unifying disparate data and allowing teams to utilize this single source of truth data will allow them to track KPIs more effectively and get key insights when they need them.

How Just-in-Time Data Can Clear the Path to First Drug Launch

Companies recognize that their success with digital starts with accurate customer data, but many struggle to manage the overwhelming volume of different data types from hundreds of sources.








Successful Digital Transformation Depends on Quality Customer Data

Rasim Shah talks about how the application of AI to Pricing and Reimbursement can dramatically free up time spent on crunching datasets, modeling scenarios, and building price predictions.

Applying AI to Pricing and Market Access

Following the introduction this week MyVeeva for Doctors, Veeva’s Paul Shawah discusses the background to the product and the role biopharma companies will play in its ongoing development.








Veeva Teams with Biopharma to Offer Industrywide Source for Key Contacts, Information, and Services 

Derek Choy is co-founder & COO of Aktana.

Digital engagement is becoming the new normal, but it can inhibit the individual connection that is foundational to building long-term customer relationships. How can reps, brand teams, and medical science liaisons strike the right balance of personal and non-personal engagement? The next generation of AI has an answer, writes Derek Choy.


